United Therapeutic
(UTHR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2011 | 09-2011 | 06-2011 | 03-2011 | 12-2010 | |
| Sales | 195,178 | 201,742 | 183,751 | 162,512 | 160,723 |
| Cost of Goods | 25,327 | 22,676 | 21,162 | 19,739 | 17,372 |
| Gross Profit | 169,851 | 179,066 | 162,589 | 142,773 | 143,351 |
| Operating Expenses | 106,669 | 76,765 | 48,258 | 106,709 | 128,365 |
| Operating Income | 63,509 | 102,977 | 114,493 | 36,803 | 15,358 |
| Interest Expense | 5,110 | 5,416 | 5,431 | 5,410 | 5,455 |
| Other Income | 785 | 695 | 552 | 670 | 913 |
| Pre-tax Income | 59,184 | 98,256 | 109,614 | 32,063 | 10,816 |
| Income Tax | 16,064 | 17,641 | 35,723 | 12,446 | -3,369 |
| Net Income Continuous | 43,120 | 80,615 | 73,891 | 19,617 | 14,185 |
| Net Income Discontinuous | 69 | 3,783 | N/A | -3,227 | -4,641 |
| Net Income | $43,189 | $84,398 | $73,891 | $16,390 | $9,544 |
| EPS Basic Total Ops | 0.81 | 1.45 | 1.27 | 0.28 | 0.17 |
| EPS Basic Continuous Ops | 0.81 | 1.38 | 1.27 | 0.34 | 0.24 |
| EPS Basic Discontinuous Ops | 0.00 | 0.07 | 0.00 | -0.06 | -0.08 |
| EPS Diluted Total Ops | 0.85 | 1.38 | 1.18 | 0.26 | 0.18 |
| EPS Diluted Continuous Ops | 0.85 | 1.32 | 1.18 | 0.31 | 0.25 |
| EPS Diluted Discontinuous Ops | 0.00 | 0.06 | 0.00 | -0.05 | -0.07 |
| EBITDA(a) | $75,187 | $113,564 | $125,151 | $48,248 | $24,525 |